Indapta Therapeutics Employee Directory
Indapta Therapeutics corporate office is located in 588 Bell St Unit 1104, Seattle, Washington, 98121, United States and has 1-10 employees.
indapta therapeutics inc
indapta therapeutics
Employees by Department
Departments
Number of employees
Medical & Health
2
Operations
2
Marketing
1
C-Suite
1
Engineering & Technical
1
Key Employees of Indapta Therapeutics
Indapta Therapeutics Global Presence
| Location | People at location |
| North America | 1-10 |
| Asia | 1-10 |
Index of contact profiles from Indapta Therapeutics
- Chief Marketing Officer, Founding
- United States , Washington , Seattle
- Clinical Operations & Scientific Strategy Cell Therapy Trial Medical Affairs Collaboration Head
- United States , Washington , Seattle
- Chief Operating Officer & Founder
- United States , Washington , Seattle
- Administrative Assistant
- United States , Washington , Seattle
- Clinical Research Associate
- United States , Washington , Seattle
- Quality Assurance
- United States , Washington , Seattle
Former Employees at Indapta Therapeutics
Explore people who held key positions, contributed to Indapta Therapeutics's success, and advanced their careers.
Global Vice President,... at BeOne Medicines
Worked as Global Head, Clinical Development (Nk-Cell The...
at Indapta Therapeutics (2025-2025)
Chief Executive Office... at Jasper Therapeutics
Worked as Co-Founder & Executive Chairman
at Indapta Therapeutics (2017-2026)
Senior Scientist - Spa... at ABSS Solutions Inc.
Worked as Scientist
at Indapta Therapeutics (2022-2024)
Medical Science Radiol... at Hologic
Worked as Clinical Research Scientist
at Indapta Therapeutics (2025-2026)
Scientist II at Cellipont Bioservices
Worked as Senior Research Associate
at Indapta Therapeutics (2022-2025)
Explore More
People from Similar Companies in the Business Services Industry Located in Washington, United States
Frequently Asked Questions Regarding Indapta Therapeutics Employees
Founded in 2017, Indapta is a privately-held company focused on developing and bringing to market a diverse pipeline of cell therapies to treat the still unmet medical needs of patients with blood and solid-tumor cancers as well as autoimmune diseases. The companys proprietary robust platform of naturally-occurring g-NK cells is specifically design... Read More
Get Started with ZoomInfo
Sign Up for Free
Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Supercharge Your Prospecting
Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.